Related Experiment Video
Updated: Jan 4, 2026

Oncogene Expression Analysis with Alterations in pH in a Pancreatic Ductal Cell Line
Published on: April 11, 2025
Pancreatitis and PDAC: association and differentiation
Sherif B Elsherif1,2, Mayur Virarkar3, Sanaz Javadi3
1The Department of Diagnostic Radiology, The University of Texas M. D. Anderson Cancer Center, 1400 Pressler St., Houston, TX, 77030, USA. sherif.b.elsherif@gmail.com.
Differentiating mass-forming chronic pancreatitis (MFCP) from pancreatic ductal adenocarcinoma (PDAC) is challenging due to overlapping imaging features. Specific signs on CT, DCE-MRI, and MRCP can suggest one over the other, but tissue sampling remains definitive.
Area of Science:
- Gastroenterology and Hepatology
- Radiology and Medical Imaging
- Surgical Oncology
Background:
- Distinguishing mass-forming chronic pancreatitis (MFCP) from pancreatic ductal adenocarcinoma (PDAC) presents a significant diagnostic challenge.
- Accurate differentiation is crucial due to the vastly different prognoses and treatment strategies for MFCP and PDAC.
- Imaging findings for MFCP and PDAC often overlap across various modalities, complicating diagnosis.
Purpose of the Study:
- To review and highlight key imaging features that aid in differentiating MFCP from PDAC.
- To discuss the utility of different imaging techniques, including CT, DCE-MRI, and MRCP, in this diagnostic process.
Main Methods:
- Review of imaging characteristics on perfusion CT, dynamic contrast-enhanced MRI (DCE-MRI), and magnetic resonance cholangiopancreatography (MRCP).
- Identification of specific signs associated with each condition, such as the duct-penetrating sign (MFCP) and the double-duct sign (PDAC).
Main Results:
- Perfusion CT and DCE-MRI may reveal distinct enhancement patterns between MFCP and PDAC.
- The duct-penetrating sign on MRCP is more indicative of MFCP.
- Abrupt main pancreatic duct cutoff with upstream dilatation and the double-duct sign are more frequently observed in PDAC.
Conclusions:
- While specific imaging features can suggest MFCP or PDAC, overlap exists.
- Tissue sampling (biopsy) is currently the most reliable method for definitive differentiation and guiding patient management.
- Further research may refine imaging criteria to improve non-invasive diagnostic accuracy.
Related Concept Videos
Chronic Pancreatitis I: Introduction
Pancreatitis is the inflammation of the pancreas, which occurs when the immune system becomes active and causes swelling, pain, and disruptions in organ function. Pancreatitis can manifest as either an acute or chronic condition.
Acute pancreatitis arises suddenly and lasts for a brief duration, while chronic pancreatitis is a long-term affliction...
Acute Pancreatitis I: Introduction
Acute pancreatitis is characterized by rapid inflammation of the pancreas, often caused by factors like gallstone blockage or excessive alcohol consumption. Chronic pancreatitis, on the other hand, is a slow, progressive inflammation that may result from long-term alcohol abuse, obstructions in the pancreatic duct, or genetic factors.
The causes of acute pancreatitis include:
Acute Pancreatitis II: Clinical Manifestations and Management
Chronic Pancreatitis II: Collaborative Care
Assessment:
Cells and Secretions of the Pancreas
Exocrine function is carried out by acinar cells, organized into clusters known as acini. These cells contribute to digestion by releasing substantial quantities of enzyme-rich, alkaline digestive juices.
Concurrently, the dispersed clusters of endocrine cells throughout the...
Pancreas
The broad head of the pancreas lies within the loop formed by the duodenum, while its slender body reaches towards the spleen. The tail of the pancreas is short...

